| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
|
J Clin Oncol
|
2003
|
17.67
|
|
2
|
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
|
Blood
|
2009
|
15.95
|
|
3
|
International consensus report on the investigation and management of primary immune thrombocytopenia.
|
Blood
|
2009
|
7.72
|
|
4
|
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
|
Blood
|
2008
|
7.06
|
|
5
|
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.
|
Lancet
|
2008
|
3.74
|
|
6
|
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
|
Haematologica
|
2008
|
2.32
|
|
7
|
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
|
Blood
|
2008
|
2.04
|
|
8
|
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL.
|
Blood
|
2013
|
1.74
|
|
9
|
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.
|
Leuk Lymphoma
|
2006
|
1.65
|
|
10
|
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
|
Blood
|
2008
|
1.57
|
|
11
|
Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.
|
Leuk Res
|
2006
|
1.54
|
|
12
|
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.
|
Blood
|
2007
|
1.53
|
|
13
|
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
|
Haematologica
|
2009
|
1.44
|
|
14
|
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
|
Haematologica
|
2009
|
1.39
|
|
15
|
Platelet transfusion and thrombotic thrombocytopenic purpura.
|
Transfusion
|
2002
|
1.39
|
|
16
|
Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.
|
Haematologica
|
2003
|
1.30
|
|
17
|
Cord-blood transplantation in patients with leukemia--a real alternative for adults.
|
N Engl J Med
|
2004
|
1.24
|
|
18
|
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.
|
Hum Mol Genet
|
2002
|
1.22
|
|
19
|
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.
|
Blood
|
2010
|
1.20
|
|
20
|
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
|
J Clin Oncol
|
2005
|
1.15
|
|
21
|
Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.
|
Biol Blood Marrow Transplant
|
2009
|
1.14
|
|
22
|
Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
|
Haematologica
|
2008
|
1.12
|
|
23
|
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
|
Blood
|
2008
|
1.11
|
|
24
|
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
|
Haematologica
|
2011
|
1.09
|
|
25
|
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
|
Mult Scler
|
2009
|
1.08
|
|
26
|
Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
|
Clin Infect Dis
|
2006
|
1.05
|
|
27
|
Viroporin activity of murine hepatitis virus E protein.
|
FEBS Lett
|
2005
|
1.05
|
|
28
|
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study.
|
Cancer
|
2003
|
1.05
|
|
29
|
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
|
Transfus Apher Sci
|
2010
|
1.03
|
|
30
|
The European LeukemiaNet: achievements and perspectives.
|
Haematologica
|
2010
|
1.02
|
|
31
|
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
|
Haematologica
|
2008
|
1.01
|
|
32
|
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
|
Cancer Sci
|
2009
|
1.01
|
|
33
|
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
|
Blood
|
2010
|
1.00
|
|
34
|
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.
|
Transfusion
|
2002
|
0.96
|
|
35
|
One-unit versus two-unit cord-blood transplantation.
|
N Engl J Med
|
2015
|
0.96
|
|
36
|
Central nervous system involvement at first relapse in patients with acute myeloid leukemia.
|
Haematologica
|
2011
|
0.95
|
|
37
|
A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
|
Blood
|
2010
|
0.95
|
|
38
|
Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
|
Thromb Res
|
2007
|
0.94
|
|
39
|
The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.
|
Mediterr J Hematol Infect Dis
|
2011
|
0.94
|
|
40
|
Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
|
Haematologica
|
2009
|
0.94
|
|
41
|
Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2009
|
0.93
|
|
42
|
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
|
Biol Blood Marrow Transplant
|
2012
|
0.92
|
|
43
|
The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
|
Haematologica
|
2007
|
0.91
|
|
44
|
Analysis of mutational status, SNP rs16754, and expression levels of Wilms tumor 1 (WT1) gene in acute promyelocytic leukemia.
|
Ann Hematol
|
2012
|
0.89
|
|
45
|
The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.
|
Leuk Res
|
2006
|
0.86
|
|
46
|
Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
|
Haematologica
|
2011
|
0.86
|
|
47
|
Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
|
Ann Hematol
|
2013
|
0.86
|
|
48
|
Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.
|
Eur J Haematol
|
2010
|
0.86
|
|
49
|
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
|
Genes Chromosomes Cancer
|
2010
|
0.86
|
|
50
|
Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q- syndrome.
|
Blood
|
2008
|
0.86
|
|
51
|
Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia.
|
Adv Hematol
|
2009
|
0.85
|
|
52
|
Biology and management of therapy-related acute promyelocytic leukemia.
|
Curr Opin Oncol
|
2013
|
0.85
|
|
53
|
Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
|
Ann Hematol
|
2004
|
0.85
|
|
54
|
Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
|
Clin Chim Acta
|
2008
|
0.84
|
|
55
|
Rapid detection of the major Mediterranean beta-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes.
|
Br J Haematol
|
2002
|
0.84
|
|
56
|
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
|
Haematologica
|
2002
|
0.83
|
|
57
|
Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia.
|
Haematologica
|
2003
|
0.83
|
|
58
|
Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting.
|
J Mol Diagn
|
2012
|
0.83
|
|
59
|
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.
|
Leuk Lymphoma
|
2009
|
0.83
|
|
60
|
Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients.
|
Ann Hematol
|
2012
|
0.82
|
|
61
|
Membrane-permeabilizing motif in Semliki forest virus E1 glycoprotein.
|
FEBS Lett
|
2004
|
0.82
|
|
62
|
Outcome of Antifungal Combination Therapy for Invasive Mold Infections in Hematological Patients is Independent of the Chosen Combination.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.82
|
|
63
|
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
|
Exp Hematol
|
2003
|
0.81
|
|
64
|
Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia.
|
Leuk Lymphoma
|
2015
|
0.81
|
|
65
|
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
|
Ann Hematol
|
2014
|
0.80
|
|
66
|
CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
|
Haematologica
|
2011
|
0.80
|
|
67
|
Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.
|
Hematology
|
2011
|
0.80
|
|
68
|
Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies.
|
Clin Chem
|
2004
|
0.80
|
|
69
|
Differential inhibition of cellular and Sindbis virus translation by brefeldin A.
|
Virology
|
2007
|
0.80
|
|
70
|
A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.
|
Curr Med Res Opin
|
2012
|
0.80
|
|
71
|
Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.
|
Haematologica
|
2002
|
0.79
|
|
72
|
De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19.
|
Genes Chromosomes Cancer
|
2003
|
0.79
|
|
73
|
Current treatment of acute promyelocytic leukemia.
|
Haematologica
|
2007
|
0.79
|
|
74
|
Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2014
|
0.79
|
|
75
|
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
|
Haematologica
|
2003
|
0.79
|
|
76
|
Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.
|
Biol Blood Marrow Transplant
|
2010
|
0.79
|
|
77
|
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
|
Cancer
|
2011
|
0.79
|
|
78
|
Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.
|
Leuk Res
|
2010
|
0.79
|
|
79
|
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
0.79
|
|
80
|
Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
|
Cancer
|
2014
|
0.79
|
|
81
|
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study.
|
Br J Haematol
|
2014
|
0.78
|
|
82
|
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
|
J Hematother Stem Cell Res
|
2002
|
0.78
|
|
83
|
A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation.
|
Int J Hematol
|
2007
|
0.78
|
|
84
|
A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
|
Cancer Genet Cytogenet
|
2006
|
0.78
|
|
85
|
A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia.
|
Leuk Lymphoma
|
2010
|
0.78
|
|
86
|
SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor.
|
Br J Haematol
|
2005
|
0.78
|
|
87
|
Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: multiinstitutional laboratory trial.
|
Clin Chem
|
2004
|
0.78
|
|
88
|
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
|
Biol Blood Marrow Transplant
|
2009
|
0.77
|
|
89
|
Unrelated-donor cord blood transplantation for adult hematological malignancies.
|
Leuk Lymphoma
|
2004
|
0.77
|
|
90
|
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
|
Ann Hematol
|
2013
|
0.77
|
|
91
|
Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4–7, 2010, Orlando, Florida.
|
Clin Adv Hematol Oncol
|
2011
|
0.77
|
|
92
|
High-level amplification of the RUNX1 gene in two cases of childhood acute lymphoblastic leukemia.
|
Cancer Genet Cytogenet
|
2006
|
0.77
|
|
93
|
Screening for IDH mutations in chronic myelomonocytic leukemia.
|
Leuk Lymphoma
|
2012
|
0.77
|
|
94
|
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.
|
BMC Infect Dis
|
2012
|
0.77
|
|
95
|
Long-term management of chronic immune thrombocytopenic purpura in adults.
|
Int J Gen Med
|
2010
|
0.77
|
|
96
|
Myeloablative cord blood transplantation in adults with acute leukemia: comparison of two different transplant platforms.
|
Biol Blood Marrow Transplant
|
2013
|
0.76
|
|
97
|
WT1 isoform expression pattern in acute myeloid leukemia.
|
Leuk Res
|
2013
|
0.76
|
|
98
|
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy.
|
Clin Lymphoma Myeloma Leuk
|
2010
|
0.76
|
|
99
|
In vitro all-trans retinoic acid sensitivity of acute myeloid leukemia blasts with NUP98/RARG fusion gene.
|
Ann Hematol
|
2014
|
0.76
|
|
100
|
Whole-genome sequencing and acute promyelocytic leukemia.
|
JAMA
|
2011
|
0.75
|
|
101
|
Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia.
|
Cancer Treat Rev
|
2003
|
0.75
|
|
102
|
[Reply].
|
Med Clin (Barc)
|
2012
|
0.75
|
|
103
|
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma.
|
Leuk Lymphoma
|
2014
|
0.75
|
|
104
|
Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia.
|
Leuk Res
|
2005
|
0.75
|
|
105
|
Effect of storage conditions on sensory properties of Bierzo roasted pepper.
|
J Sci Food Agric
|
2010
|
0.75
|
|
106
|
Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML).
|
Leuk Res
|
2011
|
0.75
|
|
107
|
Identification of two atypical PML-RAR(alpha) transcripts in two patients with acute promyelocytic leukemia.
|
Leuk Res
|
2002
|
0.75
|
|
108
|
Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients.
|
Biol Blood Marrow Transplant
|
2011
|
0.75
|
|
109
|
[Management of febrile neutropenic patients].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
110
|
Treatment of multiple myeloma in the elderly: realities and hopes.
|
Leuk Lymphoma
|
2010
|
0.75
|
|
111
|
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).
|
Hematology
|
2012
|
0.75
|
|
112
|
Effect of cultivar and roasting technique on sensory quality of Bierzo roasted pepper.
|
J Sci Food Agric
|
2011
|
0.75
|
|
113
|
[Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients].
|
Med Clin (Barc)
|
2006
|
0.75
|
|
114
|
Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML).
|
Leuk Res
|
2009
|
0.75
|
|
115
|
Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis.
|
Clin Chim Acta
|
2006
|
0.75
|
|
116
|
Landform classification for land use planning in developed areas: an example in Segovia Province (central Spain).
|
Environ Manage
|
2003
|
0.75
|
|
117
|
Basal CD34(+) cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor.
|
Haematologica
|
2004
|
0.75
|
|
118
|
Novel real-time polymerase chain reaction assay for simultaneous detection of recurrent fusion genes in acute myeloid leukemia.
|
J Mol Diagn
|
2013
|
0.75
|
|
119
|
MLL amplification in acute myeloid leukemia.
|
Cancer Genet Cytogenet
|
2007
|
0.75
|
|
120
|
[Current indications for voriconazole in onco-hematological patients].
|
Rev Iberoam Micol
|
2007
|
0.75
|